IA
CORT icon

IndexIQ Advisors’s Corcept Therapeutics CORT Stock Holding History

IndexIQ Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$374K Buy
+16,626
New +$354K 0.01% 919
2021
Q1 		– Sell
-17,615
Closed -$461K – 1170
2020
Q4 		$461K Buy
17,615
+1,818
+12% +$38.3K 0.02% 423
2020
Q3 		$275K Buy
15,797
+859
+6% +$13.7K 0.01% 450
2020
Q2 		$251K Sell
14,938
-1,052
-7% -$14.8K 0.01% 403
2020
Q1 		$190K Buy
+15,990
New +$198K 0.01% 415

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IndexIQ Advisors's CORT Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Corcept Therapeutics (CORT) in Q1 2022: 16,626 shares worth $374K. The stake represents 0.01% of the portfolio and ranks #919 among its holdings. This is a return to the name: IndexIQ Advisors previously reported a position in CORT as recently as Q4 2020.

IndexIQ Advisors first reported a position in CORT in Q1 2020 and has held it in 5 quarters since. The position peaked at $461K in Q4 2020. 228 funds tracked by Wall St. Rank hold CORT as of Q1 2022.

  • IndexIQ Advisors held 16,626 shares of Corcept Therapeutics worth $374K as of Q1 2022.
  • Corcept Therapeutics was a new IndexIQ Advisors position in Q1 2022.
  • Corcept Therapeutics made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #919 holding.
  • IndexIQ Advisors first reported a position in Corcept Therapeutics in Q1 2020 and has held it in 5 quarters since.
  • IndexIQ Advisors's Corcept Therapeutics position peaked at $461K in Q4 2020.
  • 228 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.